Published in AIDS on September 24, 2010
Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. PLoS One (2011) 1.84
Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial. Clin Infect Dis (2015) 1.76
Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss. Nat Commun (2015) 1.63
HIV infection and older Americans: the public health perspective. Am J Public Health (2012) 1.31
HIV: inflammation and bone. Curr HIV/AIDS Rep (2012) 1.23
Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B. Clin Infect Dis (2012) 1.02
Effects of smoking on non-AIDS-related morbidity in HIV-infected patients. Clin Infect Dis (2013) 1.01
Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis. AIDS (2014) 1.00
HIV and bone metabolism. Discov Med (2011) 0.95
Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study. AIDS (2014) 0.87
Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected Mediterranean subjects. BMC Infect Dis (2012) 0.84
Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan. PLoS One (2012) 0.79
Soluble CD163 is associated with shortened telomere length in HIV-infected patients. J Acquir Immune Defic Syndr (2014) 0.78
Osteopenia and osteoporosis in people living with HIV: multiprofessional approach. HIV AIDS (Auckl) (2011) 0.77
Hemin activation of innate cellular response blocks human immunodeficiency virus type-1-induced osteoclastogenesis. Biochem Biophys Res Commun (2015) 0.76
Lifetime and recent alcohol use and bone mineral density in adults with HIV infection and substance dependence. Medicine (Baltimore) (2017) 0.75
Bone mineral density in people living with HIV: a narrative review of the literature. AIDS Res Ther (2017) 0.75
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser (1994) 17.37
The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry (1974) 16.18
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90
Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet (2003) 7.94
Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol (2000) 7.77
Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet (1999) 7.14
The survival benefits of AIDS treatment in the United States. J Infect Dis (2006) 7.08
Predictive value of BMD for hip and other fractures. J Bone Miner Res (2005) 6.46
Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med (2007) 6.30
Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA (2008) 6.07
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS (2006) 5.58
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab (2008) 3.64
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS (2007) 3.04
Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc (2002) 3.03
Prediction of osteoporotic fractures by postural instability and bone density. BMJ (1993) 2.93
HIV infection and bone mineral density in middle-aged women. Clin Infect Dis (2006) 2.67
Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis (2005) 2.55
Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. JAMA (1994) 2.31
Central nervous system active medications and risk for fractures in older women. Arch Intern Med (2003) 2.30
Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis (2003) 2.20
Continuous antiretroviral therapy decreases bone mineral density. AIDS (2009) 1.96
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS (2007) 1.95
Short-term bone loss in HIV-infected premenopausal women. J Acquir Immune Defic Syndr (2010) 1.87
Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int (2003) 1.74
Longitudinal analysis of bone density in human immunodeficiency virus-infected women. J Clin Endocrinol Metab (2006) 1.72
Fracture risk associated with the use of morphine and opiates. J Intern Med (2006) 1.71
Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS (2001) 1.50
Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol (1992) 1.36
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging (2004) 1.33
Endocrine disorders in men infected with human immunodeficiency virus. Am J Med (1988) 1.32
Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend (2006) 1.32
Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study. J Acquir Immune Defic Syndr (2008) 1.26
Bone mineral density in subjects using central nervous system-active medications. Am J Med (2005) 1.19
Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol (1998) 1.18
Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients. HIV Clin Trials (2003) 1.18
Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. Clin Ther (2004) 1.17
Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis (2000) 1.16
Trochanteric bone mineral density is associated with type of hip fracture in the elderly. J Bone Miner Res (1994) 1.13
Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years. Clin Endocrinol (Oxf) (2007) 1.08
Bone mineral mass in hip fracture patients. Bone (1993) 1.05
Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection. Clin Infect Dis (2006) 1.02
Effects of chronic heroin abuse on bone and mineral metabolism. Acta Endocrinol (Copenh) (1993) 0.99
Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells. Neuroendocrinology (2000) 0.96
Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clin Infect Dis (2003) 0.95
The lifetime risk of developing prostate cancer in white and black men. Cancer Epidemiol Biomarkers Prev (1997) 0.95
Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management. Drugs Aging (1998) 0.93
Effects of heroin and methadone on plasma cortisol and testosterone. J Pharmacol Exp Ther (1975) 0.91
Heroin and naltrexone effects on pituitary-gonadal hormones in man: interaction of steroid feedback effects, tolerance and supersensitivity. J Pharmacol Exp Ther (1980) 0.83
Methionine-enkephalin in bone and joint tissues. J Bone Miner Res (1998) 0.81
Lower serum osteocalcin levels in pregnant drug users and their newborns at the time of delivery. Obstet Gynecol (1990) 0.81
Calcitonin and prolactin serum levels in heroin addicts: study on a methadone treated group. Drug Alcohol Depend (1987) 0.80
Further studies on the effects of heroin addiction on the hypothalamic-pituitary-gonadal function in man. Pharmacol Res Commun (1984) 0.79
Pituitary-gonadal function in heroin addicts. Neuropsychobiology (1977) 0.79
Acute and long-term effects of AIDS and injection drug use on gonadal function. J Acquir Immune Defic Syndr (2000) 0.78
Calcitonin serum levels in heroin addicts: effects of methadone and clonidine detoxication treatments. Drug Alcohol Depend (1985) 0.77
High serum calcitonin levels in heroin addicts. J Endocrinol Invest (1984) 0.76
Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med (2004) 3.87
Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS (2006) 3.55
Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health (2004) 2.93
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst (2003) 2.81
Use of a state-wide administrative database in assessing a regional trauma system: the New York City experience. J Am Coll Surg (2004) 2.78
The clonality of Staphylococcus aureus nasal carriage. J Infect Dis (2005) 2.39
Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. J Urban Health (2008) 2.23
Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 2.15
Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr (2003) 2.11
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS (2007) 1.95
Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis (2001) 1.79
Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis (2002) 1.73
Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.71
Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis (2003) 1.70
Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend (2006) 1.69
Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis (2002) 1.63
Some data-driven reflections on priorities in AIDS network research. AIDS Behav (2007) 1.60
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis (2003) 1.57
The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol (2009) 1.56
HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. Int J Drug Policy (2007) 1.48
Interpreting the association between HIV and bone mineral density. AIDS (2007) 1.43
Rising incidence of tumorectomies without breast radiation in patients treated for invasive breast cancer in Caribbean nations. South Med J (2010) 1.40
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis (2011) 1.37
Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis (2007) 1.37
Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated? Cancer (2010) 1.35
Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection. Clin Infect Dis (2002) 1.35
BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis (2004) 1.34
Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev (2007) 1.33
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol (2010) 1.31
HIV among injection drug users in large US metropolitan areas, 1998. J Urban Health (2005) 1.31
Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction (2003) 1.30
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer (2006) 1.28
Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.28
Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis (2003) 1.27
Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis. J Am Soc Nephrol (2013) 1.26
Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.24
Social capital or networks, negotiations, and norms? A neighborhood case study. Am J Prev Med (2007) 1.24
Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS (2007) 1.22
Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. J Acquir Immune Defic Syndr (2004) 1.21
Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women. J Acquir Immune Defic Syndr (2003) 1.20
Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women. Am J Epidemiol (2006) 1.20
The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr (2003) 1.19
Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas. Am J Public Health (2007) 1.18
Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women. Cancer Epidemiol Biomarkers Prev (2005) 1.17
Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin Infect Dis (2002) 1.14
Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992--2002): estimation methods and prevalence trends. J Urban Health (2008) 1.13
Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention. Thromb Haemost (2009) 1.13
Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol (2002) 1.12
Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users. Clin Infect Dis (2003) 1.12
Measuring thoracic excursion: reliability of the cloth tape measure technique. J Am Osteopath Assoc (2007) 1.10
"Big Events" and Networks. Connect (Tor) (2006) 1.08
For the common good: measuring residents' efforts to protect their community from drug- and sex-related harm. SAHARA J (2008) 1.06
Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis (2004) 1.04
Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: a preliminary study. Pediatrics (2002) 1.03
Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection. Clin Infect Dis (2006) 1.02
Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America. Int J Drug Policy (2006) 1.01
Clinical assessment of pediatric obstructive sleep apnea. Pediatrics (2004) 1.01
Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999. J Urban Health (2003) 0.99
Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging. AIDS (2009) 0.99
Oral methylphenidate improves spatial learning and memory in pre- and periadolescent rats. Behav Neurosci (2007) 0.98
Cardiovascular implications of HIV-induced dyslipidemia. Atherosclerosis (2011) 0.98
Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnel. J Clin Microbiol (2002) 0.98
Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study. Fertil Steril (2012) 0.96
Use of complementary and alternative medicine in inner-city persons with or at risk for HIV infection. AIDS Patient Care STDS (2008) 0.95
Antibodies to folate receptors impair embryogenesis and fetal development in the rat. Birth Defects Res A Clin Mol Teratol (2003) 0.94
Predictors of H1N1 vaccination in pregnancy. Am J Obstet Gynecol (2011) 0.94
Elevated plasma sVCAM-1 levels in children with sickle cell disease: impact of chronic transfusion therapy. Am J Hematol (2004) 0.94
Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 0.94
The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis (2002) 0.93
Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res (2003) 0.93
Bacterial vaginosis and the natural history of human papillomavirus. Infect Dis Obstet Gynecol (2011) 0.93
The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans. Hum Immunol (2011) 0.93
Prevalence of non-convulsive seizure and other electroencephalographic abnormalities in ED patients with altered mental status. Am J Emerg Med (2013) 0.92
Vaginal flora morphotypic profiles and assessment of bacterial vaginosis in women at risk for HIV infection. Infect Dis Obstet Gynecol (2005) 0.92
Incidence and persistence of Staphylococcus aureus nasal colonization in a community sample of HIV-infected and -uninfected drug users. Clin Infect Dis (2007) 0.92
Postictal psychosis in partial epilepsy: a case-control study. Ann Neurol (2008) 0.92
Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Infect Dis (2006) 0.92
Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women. J Med Microbiol (2011) 0.92
Ambient air pollution and term birth weight in Texas from 1998 to 2004. J Air Waste Manag Assoc (2012) 0.90
Medication deserts: survey of neighborhood disparities in availability of prescription medications. Int J Health Geogr (2012) 0.90
Child behavior and quality of life in pediatric obstructive sleep apnea. Arch Otolaryngol Head Neck Surg (2005) 0.89
The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women. Sex Transm Dis (2011) 0.89
Relationship of serum immunoglobulin and IgG subclass levels to race, ethnicity and behavioral characteristics in HIV infection. Med Sci Monit (2005) 0.88
Effect of microEEG on clinical management and outcomes of emergency department patients with altered mental status: a randomized controlled trial. Acad Emerg Med (2014) 0.88
Human leukocyte antigen class I supertypes and HIV-1 control in African Americans. J Virol (2009) 0.88
Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users. J Acquir Immune Defic Syndr (2006) 0.87
Hepatitis C virus infection is associated with insulin resistance among older adults with or at risk of HIV infection. AIDS (2007) 0.87
Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: Risk factors and severity. Obstet Gynecol (2003) 0.87
Nutritional biomarkers associated with gynecological conditions among US women with or at risk of HIV infection. Am J Clin Nutr (2007) 0.85
Aging and HIV infection. J Urban Health (2006) 0.85
Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus. Am J Obstet Gynecol (2003) 0.85
New-onset diabetes after hemodialysis initiation: impact on survival. Am J Nephrol (2010) 0.85
Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression. J Acquir Immune Defic Syndr (2008) 0.85
Association between semen exposure and incident bacterial vaginosis. Infect Dis Obstet Gynecol (2011) 0.85
The multiple shark Ig H chain genes rearrange and hypermutate autonomously. J Immunol (2011) 0.84
The utility of the forced oscillation technique in assessing bronchodilator responsiveness in patients with asthma. Respir Med (2006) 0.84
A community-based study of hepatitis B infection and immunization among young adults in a high-drug-use neighborhood in New York City. J Urban Health (2005) 0.84
Racial/ethnic differences in the prevalence of snoring and sleep disordered breathing in young children. J Clin Sleep Med (2011) 0.84
Adherence to zidovudine for the prevention of perinatal transmission in HIV-infected pregnant women: the impact of social network factors, side effects, and perceived treatment efficacy. Women Health (2005) 0.84
Correlation of optic nerve sheath diameter measurements by computed tomography and magnetic resonance imaging. Am J Emerg Med (2013) 0.84